Sirnaomics Partners with Bloomage Biotech for Next-Gen Life Science Advancements Sirnaomics has announced a significant investment from Bloomage Biotech, focusing on enhancing RNAi therapeutic development and commercialization collaborations.

Sirnaomics Partners with Bloomage Biotech for Next-Gen Life Science Advancements #Hong_Kong #RNAi_Technology #Sirnaomics #Bloomage_Biotech

The Growing RNAi Technology Market Set to Reach USD 6.63 Billion by 2033 The RNAi technology market is projected to soar from USD 2.75 billion in 2024 to USD 6.63 billion by 2033, driven by innovative therapeutics and strong demand.

The Growing RNAi Technology Market Set to Reach USD 6.63 Billion by 2033 #USA #Austin #Alnylam_Pharmaceuticals #RNAi_Technology #Gene_Silencing